// App-Quantinova.ai

797 : A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer

Researchers

Presenter

  • Alice W. Lee

Principal Investigators

  • Elisa V. Bandera

  • Allan Jensen

  • Susan J. Ramus

  • Marc T. Goodman

  • Mary Anne Rossing

  • Francesmary Modugno

  • Kirsten B. Moysich

  • Jenny Chang-Claude

  • Anja Rudolph

  • Aleksandra Gentry-Maharaj

  • Kathryn L. Terry

  • Simon A. Gayther

  • Daniel W. Cramer

  • Jennfier A. Doherty

  • Joellen M. Schildkraut

  • Susanne K. Kjaer

  • Roberta B. Ness

  • Usha Menon

  • Andrew Berchuck

  • Bhramar Mukherjee

  • Lynda Roman

  • Paul D. Pharoah

  • Georgia Chenevix-Trench

  • Anna H. Wu

  • Malcolm C. Pike

  • Celeste L. Pearce

Medical Centers

  • University of Southern California, Los Angeles, CA

  • University of Michigan, Ann Arbor, MI

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

  • Danish Cancer Society Research Center, Copenhagen, Denmark

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • University of Pittsburgh, School of Medicine, Pittsburgh, PA

  • Roswell Park Cancer Institute, Buffalo, NY

  • German Cancer Research Centre, Heidelberg, Germany

  • Kings College London, London, United Kingdom

  • Brigham and Women's Hospital, Brookline, MA

  • Geisel School of Medcn At Dartmouth, Lebanon, NH

  • University of Virgina, Charlottesville, VA

  • University of Texas School of Public Health, Houston, TX

  • Duke University Medical Center, Durham, NC

  • University of Cambridge, Cambridge, United Kingdom

  • QIMR Berghofer Medical Research Institute, Brisbane, Sydney, Australia

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • Germany

  • United Kingdom

  • Australia

  • United States

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Telomerase reverse transcriptase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved